Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-25 @ 4:08 AM
NCT ID:
NCT06321120
Eligibility Criteria:
Inclusion Criteria:
1. Age 18-80 years
2. Lenvatinib treated cancer patients, who suffer from loss of response of dose-limiting adverse effects.
Exclusion Criteria:
1. Current or history of drug abuse
2. Pregnancy/lactation/planned pregnancy
3. The subject is currently enrolled in or has not yet completed at least 60 days since ending another investigational device or drug trial.
4. Unable to comply with study requirements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06321120
Study Brief:
Protocol Section:
NCT06321120